Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

128 - Introducing HelixTalk’s 2021 Drug Superlative Awards!

128 - Introducing HelixTalk’s 2021 Drug Superlative Awards!

FromHelixTalk - Rosalind Franklin University's College of Pharmacy Podcast


128 - Introducing HelixTalk’s 2021 Drug Superlative Awards!

FromHelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

ratings:
Length:
47 minutes
Released:
Mar 30, 2021
Format:
Podcast episode

Description

In this episode, we announce the debut of the HelixTalk Drug Superlative Awards -- awards given to medications on the market that are outstanding or notorious. In announcing these completely fictitious awards, we review key clinical pearls and pitfalls that every clinician should be aware of with these medications. Key Concepts Drug most likely to be remembered for COVID-19 ineffectiveness rather than its actual FDA indication: hydroxychloroquine Commonly used but worst hypertensives on the market: it’s a tie! Atenolol and hydrochlorothiazide. Most confusing dosage forms: valproic acid, valproate sodium, and divalproex -- it’s all the same thing! Most innovative prodrug: valacyclovir Hottest inactive ingredient: it’s a tie! Sulfobutylether-beta-cyclodextrin (SBECD), an excipient in remdesivir, and polyethylene glycol (PEG), an excipient in mRNA vaccines.
Released:
Mar 30, 2021
Format:
Podcast episode

Titles in the series (100)

Educational podcast presented by the Rosalind Franklin University College of Pharmacy. This podcast is produced by our pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.